190 related articles for article (PubMed ID: 17565006)
1. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
[TBL] [Abstract][Full Text] [Related]
2. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis.
Machida T; Heerdt PM; Reid AC; Schäfer U; Silver RB; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2005 May; 313(2):570-7. PubMed ID: 15647328
[TBL] [Abstract][Full Text] [Related]
3. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
4. Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia.
Sesti C; Koyama M; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2003 Jul; 306(1):238-44. PubMed ID: 12676879
[TBL] [Abstract][Full Text] [Related]
5. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
6. The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons.
Corti F; Olson KE; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2011 May; 337(2):524-32. PubMed ID: 21325440
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
8. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
[TBL] [Abstract][Full Text] [Related]
9. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.
Mizumoto N; Kumamoto T; Robson SC; Sévigny J; Matsue H; Enjyoji K; Takashima A
Nat Med; 2002 Apr; 8(4):358-65. PubMed ID: 11927941
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
[TBL] [Abstract][Full Text] [Related]
11. NTPDase1 governs P2X7-dependent functions in murine macrophages.
Lévesque SA; Kukulski F; Enjyoji K; Robson SC; Sévigny J
Eur J Immunol; 2010 May; 40(5):1473-85. PubMed ID: 20201036
[TBL] [Abstract][Full Text] [Related]
12. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
13. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.
Alvarado-Castillo C; Harden TK; Boyer JL
Mol Pharmacol; 2005 Jan; 67(1):114-22. PubMed ID: 15496502
[TBL] [Abstract][Full Text] [Related]
14. EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release.
Sesti C; Broekman MJ; Drosopoulos JH; Islam N; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2002 Feb; 300(2):605-11. PubMed ID: 11805223
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
[TBL] [Abstract][Full Text] [Related]
16. Decreased ecto-NTPDase1/CD39 activity leads to desensitization of P2 purinoceptors regulating tonus of corpora cavernosa in impotent men with endothelial dysfunction.
Faria M; Magalhães-Cardoso T; Lafuente-de-Carvalho JM; Correia-de Sá P
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):761-8. PubMed ID: 18600538
[TBL] [Abstract][Full Text] [Related]
17. Extracellular ATP in activity-dependent remodeling of the neuromuscular junction.
Jia M; Li MX; Fields RD; Nelson PG
Dev Neurobiol; 2007 Jun; 67(7):924-32. PubMed ID: 17506503
[TBL] [Abstract][Full Text] [Related]
18. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R
J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
[TBL] [Abstract][Full Text] [Related]
19. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes.
Koziak K; Sévigny J; Robson SC; Siegel JB; Kaczmarek E
Thromb Haemost; 1999 Nov; 82(5):1538-44. PubMed ID: 10595651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
